With innovation leading to the increasing integration of drugs and devices, traditional boundaries between medicines and medical devices are often blurred. As a result, determining the correct regulatory pathway for drug-device combination products (DDCs) can prove challenging.
The development of these products involves interaction between EU and national regulations, one of which, the Medical Devices Regulation (MDR), is set to become fully applicable on 26 May 2021.
In this briefing we examine the key changes to the regulatory pathway for DDCs.
Click here or on the image below to download this briefing, or click the following links to view the rest of our series:
- Our Medical Devices Publication
To assist medical device companies navigate the new MDR & IVDR regulatory regime we published under one roof the Regulations with easy access to the annexes and a table of equivalence comparing key articles from the Medical Devices Directives 93/42/EEC and 90/385/EEC and In Vitro Diagnostic Medical Devices Directive 98/79/EC with the MDR & IVDR. - Low Rate of Notified Body Designations under MDR and IVDR Causes Bottleneck Concerns for the European MedTech Industry
We explore which EU Notified Bodies have been designated under the new Medical Devices and In-Vitro Devices Regulations, and the slow pace of approval despite increased demand for their services. - Act Now to be Ready on Time – Guide to New Classification Rules for In Vitro Diagnostic Medical Devices
We outline the key changes to the classification of in vitro diagnostic medical devices in advance of the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) becoming fully applicable on 26 May 2022. - Medical Devices – New Classification Rules – Is your Business Ready?
A guide to the classification of devices under the new Medical Devices Regulation.
Recommended Insights
Article and Insights
1
Nov 2024
We are delighted to announce that Stephen Keogh has formally taken up the role of ...
Managing Partner
Stephen Keogh
Article and Insights
1
Nov 2024
On 31 October 2024, the Minister of State for Trade Promotion, Digital and Company...
Partner
Barry Scannell
Article and Insights
29
Oct 2024
William Fry's Financial Regulation team examines key themes highlighted by the Cen...
Partner
Shane Kelleher
Article and Insights
5
Nov 2024
The Government has approved and published the Terms and Conditions for Ireland's s...
Partner
Fergus Devine
Article and Insights
25
Oct 2024
William Fry is pleased to have acted as lead Irish counsel to Grant Thornton Advis...
Partner
Ivor Banim
Article and Insights
24
Oct 2024
Privy Council decision on arbitration agreements in insolvency cases.
Partner
Ruairi Rynn
prev
next